Dow Up 0.82% Nasdaq Up 0.70%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqCM
0.43 Up 0.05(13.16%) May 25, 3:59PM EDT
Prev Close:0.38
Open:0.38
Bid:0.31 x 400
Ask:0.85 x 100
1y Target Est:5.00
Beta:4.55065
Earnings Date:Aug 9 - Aug 15 (Est.)
Day's Range:0.35 - 0.44
52wk Range:0.30 - 1.05
Volume:432,380
Avg Vol (3m):107,060
Market Cap:14.92M
P/E (ttm):N/A
EPS (ttm):-0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYCC

Comparison

Symbol% ChgMkt Cap
CYCCUp 13.16%14.92M
JNJUp 0.59%311.79B
AZNUp 1.70%75.85B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :N/A
Quarterly EPS Est (Mar-16) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs for the treatment of cancer and other diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback